By Administrator_India Capital Sands Zydus has received approval from Indian regulators to begin human studies for its COVID-19 vaccine contender, the drugmaker said on Friday, as the novel coronavirus infections continue to surge in the world’s fourth worst-hit nation. The…
By Administrator_India Capital Sands As nations race to develop treatments and vaccines for COVID-19, Japan has become a victim of its own success as slowing new infections has led to a shortage of patients to enroll in clinical trials. Clinical…
By Administrator_India Capital Sands The city of New Delhi on Sunday ordered many of its hospital beds to be reserved solely for residents of the Indian capital, as the number of COVID-19 infections continued to surge. India on Sunday registered…
By Administrator_India Capital Sands The World Health Organization on Tuesday promised a swift review of data on hydroxychloroquine, probably by mid-June, after safety concerns prompted the group to suspend the malaria drug’s use in a large trial on COVID-19 patients….
By Administrator_India Capital Sands France’s death toll from the coronavirus rose by 348 to 26,991 on Tuesday, overtaking Spain to become the country with the world’s fourth-highest number of fatalities after the United States, Britain and Italy. Official data had…
